To assess the efficacy of Ginsana in improving hemoglobin re-oxygenation in healthy, recreational sports people and to assess the safety of the product.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
26
Baseline-adjusted half-time hemoglobin re-oxygenation
Time frame: day 84
Baseline-adjusted half-time hemoglobin re-oxygenation
Time frame: day 21, 42 and 63
maximum endurance time
Time frame: day 21, day 42, day 63 and day 84
Change from baseline in respiratory threshold
Time frame: Baseline, up to day 84
Change from baseline in thiobarbituric acid (TBARS)
Time frame: Baseline, up to day 84
Change from baseline in glutathione superdismutase/glutathione superdismutase oxidised (GSG/GSSG) ratio
Time frame: Baseline, up to day 84
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.